1887

Abstract

Human herpesvirus 6 (HHV-6) exists as distinct variants HHV-6A and HHV-6B. The complete genomes of HHV-6A and HHV-6B have been sequenced. HHV-6B contains 97 unique genes. CD46 is the cell receptor for HHV-6, explaining its broad tissue tropism but its restricted host-species range. HHV-6 utilizes a number of strategies to down-regulate the host immune response, including molecular mimicry by production of a functional chemokine and chemokine receptors. Immunosuppression is enhanced by depletion of CD4 T lymphocytes via direct infection of intra-thymic progenitors and by apoptosis induction. Infection is widespread in infants between 6 months and 2 years of age. A minority of infants develop roseola infantum, but undifferentiated febrile illness is more common. Reactivation from latency occurs in immunocompromised hosts. Organ-specific clinical syndromes occasionally result, but indirect effects including interactions with other viruses such as human immunodeficiency virus type 1 and human cytomegalovirus or graft dysfunction in transplant recipients may be more significant complications in this population. Recent advances in quantitative PCR are providing additional insights into the natural history of infection in paediatric populations and immunocompromised hosts.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05074-0
2003-01-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/1/5.html?itemId=/content/journal/jmm/10.1099/jmm.0.05074-0&mimeType=html&fmt=ahah

References

  1. Ablashi, D., Agut, H., Berneman, Z. & 29 other authors ( 1993;). Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 129, 363–366.[CrossRef]
    [Google Scholar]
  2. Akashi, K., Eizuru, Y., Sumiyoshi, Y., Minematsu, T., Hara, S., Harada, M., Kikuchi, M., Niho, Y. & Minamishima, Y. ( 1993;). Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 329, 168–171.[CrossRef]
    [Google Scholar]
  3. Akhyani, N., Berti, R., Brennan, M. B., Soldan, S. S., Eaton, J. M., McFarland, H. F. & Jacobson, S. ( 2000;). Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182, 1321–1325.[CrossRef]
    [Google Scholar]
  4. Anderson, R. A., Liu, D. X. & Gompels, U. A. ( 1996;). Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 217, 517–526.[CrossRef]
    [Google Scholar]
  5. Ansari, A. & Emery, V. C. ( 1999;). The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol 73, 3284–3291.
    [Google Scholar]
  6. Asada, H., Klaus-Kovtun, V., Golding, H., Katz, S. I. & Blauvelt, A. ( 1999;). Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol 73, 4019–4028.
    [Google Scholar]
  7. Ashshi, A. M., Cooper, R. J., Klapper, P. E., Al-Jiffri, O. & Moore, L. ( 2000;). Detection of human herpes virus 6 DNA in fetal hydrops. Lancet 355, 1519–1520.[CrossRef]
    [Google Scholar]
  8. Bandobashi, K., Daibata, M., Kamioka, M., Tanaka, Y., Kubonishi, I., Taguchi, H., Ohtsuki, Y. & Miyoshi, I. ( 1997;). Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: establishment of a novel cell line infected with HHV-6. Blood 90, 1200–1207.
    [Google Scholar]
  9. Berneman, Z. N., Ablashi, D. V., Li, G., Eger-Fletcher, M., Reitz, M. S., Jr, Hung, C. L., Brus, I., Komaroff, A. L. & Gallo, R. C. ( 1992;). Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A 89, 10552–10556.[CrossRef]
    [Google Scholar]
  10. Brown, N. A., Sumaya, C. V., Liu, C.-R., Ench, Y., Kovacs, A., Coronesi, M. & Kaplan, M. H. ( 1988;). Fall in human herpesvirus 6 seropositivity with age. Lancet ii, 396.
    [Google Scholar]
  11. Burd, E. M. & Carrigan, D. R. ( 1993;). Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res 29, 79–90.[CrossRef]
    [Google Scholar]
  12. Burd, E. M., Knox, K. K. & Carrigan, D. R. ( 1993;). Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures. Blood 81, 1645–1650.
    [Google Scholar]
  13. Cardinali, G., Gentile, M., Cirone, M., Zompetta, C., Frati, L., Faggioni, A. & Torrisi, M. R. ( 1998;). Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human herpesvirus 6. J Virol 72, 9738–9746.
    [Google Scholar]
  14. Carrigan, D. R. ( 1995;). Human herpesvirus-6 and bone marrow transplantation. Blood 85, 294–295.
    [Google Scholar]
  15. Carrigan, D. R. & Knox, K. K. ( 1994;). Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 84, 3307–3310.
    [Google Scholar]
  16. Carrigan, D. R., Knox, K. K. & Tapper, M. A. ( 1990;). Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Infect Dis 162, 844–851.[CrossRef]
    [Google Scholar]
  17. Carrigan, D. R., Drobyski, W. R., Russler, S. K., Tapper, M. A., Knox, K. K. & Ash, R. C. ( 1991;). Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338, 147–149.[CrossRef]
    [Google Scholar]
  18. Caserta, M. T., Mock, D. J. & Dewhurst, S. ( 2001;). Human herpesvirus 6. Clin Infect Dis 33, 829–833.[CrossRef]
    [Google Scholar]
  19. Challoner, P. B., Smith, K. T., Parker, J. D. & 12 other authors ( 1995;). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92, 7440–7444.[CrossRef]
    [Google Scholar]
  20. Chang, F. Y., Singh, N., Gayowski, T., Wagener, M. M. & Marino, I. R. ( 1998;). Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 26, 59–65.[CrossRef]
    [Google Scholar]
  21. Chiu, S. S., Cheung, C. Y., Tse, C. Y. C. & Peiris, M. ( 1998;). Early diagnosis of primary human herpesvirus 6 infection in childhood: serology, polymerase chain reaction, and virus load. J Infect Dis 178, 1250–1256.[CrossRef]
    [Google Scholar]
  22. Chou, S. & Marousek, G. I. ( 1992;). Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus. Virology 191, 523–528.[CrossRef]
    [Google Scholar]
  23. Chou, S. W. & Scott, K. M. ( 1990;). Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection. J Clin Microbiol 28, 851–854.
    [Google Scholar]
  24. Chua, K. B., Lam S. K., AbuBakar, S., Lim, S. T., Paranjothy, M., Koh, M. T. & Lee, W. S. ( 2000;). The predictive value of uvulo-palatoglossal junctional ulcers as an early clinical sign of exanthem subitum due to human herpesvirus 6. J Clin Virol 17, 83–90.[CrossRef]
    [Google Scholar]
  25. Clark, D. A. ( 2000;). Human herpesvirus 6. Rev Med Virol 10, 155–173.[CrossRef]
    [Google Scholar]
  26. Clark, D. A., Kidd, I. M., Collingham, K. E., Tarlow, M., Ayeni, T., Riordan, A., Griffiths, P. D., Emery, V. C. & Pillay, D. ( 1997;). Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction. Arch Dis Child 77, 42–45.[CrossRef]
    [Google Scholar]
  27. Coates, A. R. & Bell, J. ( 1998;). HHV-6 and multiple sclerosis. Nat Med 4, 537–538.[CrossRef]
    [Google Scholar]
  28. Cone, R. W., Hackman, R. C., Huang, M. L., Bowden, R. A., Meyers, J. D., Metcalf, M., Zeh, J., Ashley, R. & Corey, L. ( 1993;). Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329, 156–161.[CrossRef]
    [Google Scholar]
  29. Cone, R. W., Huang, M. W. & Hackman, R. C. ( 1994;). Human herpesvirus 6 and pneumonia. Leuk Lymphoma 15, 235–241.[CrossRef]
    [Google Scholar]
  30. Cone, R. W., Huang, M. L., Hackman, R. C. & Corey, L. ( 1996;). Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 34, 877–881.
    [Google Scholar]
  31. Corbellino, M., Lusso, P., Gallo, R. C., Parravicini, C., Galli, M. & Moroni, M. ( 1993;). Disseminated human herpesvirus 6 infection in AIDS. Lancet 342, 1242.
    [Google Scholar]
  32. Dahl, H., Fjaertoft, G., Norsted, T., Wang, F. Z., Mousavi-Jazi, M. & Linde, A. ( 1999;). Reactivation of human herpesvirus 6 during pregnancy. J Infect Dis 180, 2035–2038.[CrossRef]
    [Google Scholar]
  33. Daibata, M., Taguchi, T., Nemoto, Y., Taguchi, H. & Miyoshi, I. ( 1999;). Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood 94, 1545–1549.
    [Google Scholar]
  34. Deng, H. & Dewhurst, S. ( 1998;). Functional identification and analysis of cis-acting sequences which mediate genome cleavage and packaging in human herpesvirus 6. J Virol 72, 320–329.
    [Google Scholar]
  35. DesJardin, J. A., Gibbons, L., Cho, E., Supran, S. E., Falagas, M. E., Werner, B. G. & Snydman, D. R. ( 1998;). Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 178, 1783–1786.[CrossRef]
    [Google Scholar]
  36. DesJardin, J. A., Cho, E., Supran, S., Gibbons, L., Werner, B. G. & Snydman, D. R. ( 2001;). Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 33, 1358–1362.[CrossRef]
    [Google Scholar]
  37. Dockrell, D. H. & Paya, C. V. ( 2001;). Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11, 23–36.[CrossRef]
    [Google Scholar]
  38. Dockrell, D. H., Prada, J., Jones, M. F. & 8 other authors ( 1997;). Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 176, 1135–1140.[CrossRef]
    [Google Scholar]
  39. Dockrell, D. H., Smith, T. F. & Paya, C. V. ( 1999;a). Human herpesvirus 6. Mayo Clin Proc 74, 163–170.[CrossRef]
    [Google Scholar]
  40. Dockrell, D. H., Mendez, J. C., Jones, M., Harmsen, W. S., Ilstrup, D. M., Smith, T. F., Wiesner, R. H., Krom, R. A. & Paya, C. V. ( 1999;b). Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 67, 399–403.[CrossRef]
    [Google Scholar]
  41. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N. & Pellett, P. E. ( 1999;). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73, 8040–8052.
    [Google Scholar]
  42. Drobyski, W. R., Dunne, W. M., Burd, E. M., Knox K. K., Ash, R. C., Horowitz, M. M., Flomenberg, N. & Carrigan, D. R. ( 1993;). Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role of HHV-6 in vivo. J Infect Dis 167, 735–739.[CrossRef]
    [Google Scholar]
  43. Emery, V. C. ( 2001;). Human herpesviruses 6 and 7 in solid organ transplant recipients. Clin Infect Dis 32, 1357–1360.[CrossRef]
    [Google Scholar]
  44. Emery, V. C., Atkins, M. C., Bowen, E. F. & 7 other authors ( 1999;). Interactions between β-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J Med Virol 57, 278–282.[CrossRef]
    [Google Scholar]
  45. Fairfax, M. R., Schacker, T., Cone, R. W., Collier, A. C. & Corey, L. ( 1994;). Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts. J Infect Dis 169, 1342–1345.[CrossRef]
    [Google Scholar]
  46. Flamand, L., Gosselin, J., D'Addario, M., Hiscott, J., Ablashi, D. V., Gallo, R. C. & Menezes, J. ( 1991;). Human herpesvirus 6 induces interleukin-1β and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65, 5105–5110.
    [Google Scholar]
  47. Flamand, L., Stefanescu, I., Ablashi, D. V. & Menezes, J. ( 1993;). Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 67, 6768–6777.
    [Google Scholar]
  48. Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D. & Menezes, J. ( 1995;). Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 85, 1263–1271.
    [Google Scholar]
  49. Flamand, L., Stefanescu, I. & Menezes, J. ( 1996;). Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 97, 1373–1381.[CrossRef]
    [Google Scholar]
  50. Flamand, L., Romerio, F., Reitz, M. S. & Gallo, R. C. ( 1998;). CD4 promoter transactivation by human herpesvirus 6. J Virol 72, 8797–8805.
    [Google Scholar]
  51. Flebbe-Rehwaldt, L. M., Wood, C. & Chandran, B. ( 2000;). Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J Virol 74, 11040–11054.[CrossRef]
    [Google Scholar]
  52. French, C., Menegazzi, P., Nicholson, L., Macaulay, H., DiLuca, D. & Gompels, U. A. ( 1999;). Novel, nonconsensus cellular splicing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is specific for human herpesvirus 6. Virology 262, 139–151.[CrossRef]
    [Google Scholar]
  53. Gautheret-Dejean, A., Manichanh, C., Thien-Ah-Koon, F., Fillet, A. M., Mangeney, N., Vidaud, M., Dhedin, N., Vernant, J. P. & Agut, H. ( 2002;). Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100, 27–35.[CrossRef]
    [Google Scholar]
  54. Gobbi, A., Stoddart, C. A., Malnati, M. S. & 9 other authors ( 1999;). Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J Exp Med 189, 1953–1960.[CrossRef]
    [Google Scholar]
  55. Gobbi, A., Stoddart, C. A., Locatelli, G. & 9 other authors ( 2000;). Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1. J Virol 74, 8726–8731.[CrossRef]
    [Google Scholar]
  56. Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J., Martin, M. E., Efstathiou, S., Craxton, M. & Macaulay, H. A. ( 1995;). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209, 29–51.[CrossRef]
    [Google Scholar]
  57. Gosselin, J., Tomolu, A., Gallo, R. C. & Flamand, L. ( 1999;). Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94, 4210–4219.
    [Google Scholar]
  58. Gravel, A., Gosselin, J. & Flamand, L. ( 2002;). Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J Biol Chem 277, 19679–19687.[CrossRef]
    [Google Scholar]
  59. Griffiths, P. D., Ait-Khaled, M., Bearcroft, C. R. & 11 other authors ( 1999;). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 59, 496–501.[CrossRef]
    [Google Scholar]
  60. Griffiths, P. D., Clark, D. A. & Emery, V. C. ( 2000;). Betaherpesviruses in transplant recipients. J Antimicrob Chemother 45 (Suppl. T3), 29–34.[CrossRef]
    [Google Scholar]
  61. Grivel, J.-C., Ito, Y., Faga, G., Santoro, F., Shaheen, F., Malnati, M. S., Fitzgerald, W., Lusso, P. & Margolis, L. ( 2001;). Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7, 1232–1235.[CrossRef]
    [Google Scholar]
  62. Hall, C. B. ( 1997;). Human herpesviruses at sixes, sevens, and more. Ann Intern Med 127, 481–483.[CrossRef]
    [Google Scholar]
  63. Hall, C. B., Long, C. E., Schnabel, K. C. & 7 other authors ( 1994;). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331, 432–438.[CrossRef]
    [Google Scholar]
  64. Hall, C. B., Caserta, M. T., Schnabel, K. C., Long, C., Epstein, L. G., Insel, R. A., Dewhurst, S. ( 1998;). Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 26, 132–137.[CrossRef]
    [Google Scholar]
  65. Hasegawa, A., Yasukawa, M., Sakai, I. & Fujita, S. ( 2001;). Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J Immunol 166, 1125–1131.[CrossRef]
    [Google Scholar]
  66. He, J., McCarthy, M., Zhou, Y., Chandran, B. & Wood, C. ( 1996;). Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70, 1296–1300.
    [Google Scholar]
  67. Herbein, G., Strasswimmer, J., Altieri, M., Woehl-Jaegle, M. L., Wolf, P. & Obert, G. ( 1996;). Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 22, 171–173.[CrossRef]
    [Google Scholar]
  68. Humar, A., Malkan, G., Moussa, G., Greig, P., Levy, G. & Mazzulli, T. ( 2000;). Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 181, 1450–1453.[CrossRef]
    [Google Scholar]
  69. Humar, A., Kumar, D., Caliendo, A. M., Moussa, G., Ashi-Sulaiman, A., Levy, G. & Mazzulli, T. ( 2002;). Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 73, 599–604.[CrossRef]
    [Google Scholar]
  70. Ichimi, R., Jin-no, T. & Ito, M. ( 1999;). Induction of apoptosis in cord blood lymphocytes by HHV-6. J Med Virol 58, 63–68.[CrossRef]
    [Google Scholar]
  71. Imbert-Marcille, B. M., Tang, X. W., Lepelletier, D., Besse, B., Moreau, P., Billaudel, S. & Milpied, N. ( 2000;). Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 31, 881–886.[CrossRef]
    [Google Scholar]
  72. Inagi, R., Guntapong, R., Nakao, M., Ishino, Y., Kawanishi, K., Isegawa, Y. & Yamanishi, K. ( 1996;). Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2. J Med Virol 49, 34–40.[CrossRef]
    [Google Scholar]
  73. Inoue, Y., Yasukawa, M. & Fujita, S. ( 1997;). Induction of T-cell apoptosis by human herpesvirus 6. J Virol 71, 3751–3759.
    [Google Scholar]
  74. Irving, W. L. & Cunningham, A. L. ( 1990;). Serological diagnosis of infection with human herpesvirus type 6. BMJ 300, 156–159.[CrossRef]
    [Google Scholar]
  75. Irving, W. L., Ratnamohan, V. M., Hueston, L. C., Chapman, J. R. & Cunningham, A. L. ( 1990;). Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses. J Infect Dis 161, 910–916.[CrossRef]
    [Google Scholar]
  76. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N. & Yamanishi, K. ( 1998;). Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 72, 6104–6112.
    [Google Scholar]
  77. Isegawa, Y., Mukai, T., Nakano, K. & 10 other authors ( 1999;). Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73, 8053–8063.
    [Google Scholar]
  78. Isomura, H., Yamada, M., Yoshida, M., Tanaka, H., Kitamura, T., Oda, M., Nii, S. & Seino, Y. ( 1997;). Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 52, 406–412.[CrossRef]
    [Google Scholar]
  79. Jacobs, U., Ferber, J. & Klehr, H. U. ( 1994;). Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation. Transplant Proc 26, 3121.
    [Google Scholar]
  80. Kashanchi, F., Araujo, J., Doniger, J. & 10 other authors ( 1997;). Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14, 359–367.[CrossRef]
    [Google Scholar]
  81. Kasolo, F. C., Mpabalwani, E. & Gompels, U. A. ( 1997;). Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 78, 847–856.
    [Google Scholar]
  82. Katsafanas, G. C., Schirmer, E. C., Wyatt, L. S. & Frenkel, N. ( 1996;). In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci U S A 93, 9788–9792.[CrossRef]
    [Google Scholar]
  83. Kempf, W., Adams, V., Wey, N., Moos, R., Schmid, M., Avitabile, E. & Campadelli-Fiume, G. ( 1997;). CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci U S A 94, 7600–7605.[CrossRef]
    [Google Scholar]
  84. Kidd, I. M., Clark, D. A., Bremner, J. A. G., Pillay, D., Griffiths, P. D. & Emery, V. C. ( 1998;). A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 70, 29–36.[CrossRef]
    [Google Scholar]
  85. Kidd, I. M., Clark, D. A., Sabin, C. A., Andrew, D., Hassan-Walker, A. F., Sweny, P., Griffiths, P. D. & Emery, V. C. ( 2000;). Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 69, 2400–2404.[CrossRef]
    [Google Scholar]
  86. Kirn, E., Krueger, E., Boehmer, S., Klussmann, J. P. & Krueger, G. R. ( 1997;). In vitro cytobiological effects of human herpesviruses 6 and 7: immunohistological monitoring of apoptosis, differentiation and cell proliferation. Anticancer Res 17, 4623–4632.
    [Google Scholar]
  87. Knowles, W. A. & Gardner, S. D. ( 1988;). High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants. Lancet ii, 912–913.
    [Google Scholar]
  88. Knox, K. K. & Carrigan, D. R. ( 1992;). In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 165, 925–929.[CrossRef]
    [Google Scholar]
  89. Knox, K. K., Brewer, J. H., Henry, J. M., Harrington, D. J. & Carrigan, D. R. ( 2000;). Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis 31, 894–903.[CrossRef]
    [Google Scholar]
  90. Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K. & Yamanashi, K. ( 2002;). Identification of human herpesvirus 6 latency-associated transcripts. J Virol 76, 4145–4151.[CrossRef]
    [Google Scholar]
  91. Kositanont, U., Wasi, C., Wanprapar, N. & 9 other authors ( 1999;). Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficiency virus type 1. J Infect Dis 180, 50–55.[CrossRef]
    [Google Scholar]
  92. Kosuge, H., Tanaka-Taya, K., Miyoshi, H., Amo, K., Harada, R., Ebihara, T., Kawahara, Y., Yamanishi, K. & Nishikawa, T. ( 2000;). Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea. Br J Dermatol 143, 795–798.[CrossRef]
    [Google Scholar]
  93. Krueger, G. R., Koch, B., Leyssens, N. & 11 other authors ( 1998;). Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countries. Vox Sang 75, 193–197.[CrossRef]
    [Google Scholar]
  94. Lanphear, B. P., Hall, C. B., Black, J. & Auinger, P. ( 1998;). Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children. Pediatr Infect Dis J 17, 792–795.[CrossRef]
    [Google Scholar]
  95. Lau, Y. L., Peiris, M., Chan, G. C., Chan, A. C., Chiu, D. & Ha, S. Y. ( 1998;). Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion. Bone Marrow Transplant 21, 1063–1066.[CrossRef]
    [Google Scholar]
  96. Lautenschlager, I., Hockerstedt, K., Linnavuori, K. & Taskinen, E. ( 1998;). Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26, 702–707.[CrossRef]
    [Google Scholar]
  97. Lautenschlager, I., Hockerstedt, K., Linnavuori, K. & Taskinen, E. ( 1999;). Human herpesvirus 6 infection increases adhesion molecule expression in liver allografts. Transplant Proc 31, 479–480.[CrossRef]
    [Google Scholar]
  98. Lautenschlager, I., Linnavuori, K. & Hockerstedt, K. ( 2000;). Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69, 2561–2566.[CrossRef]
    [Google Scholar]
  99. Levy, J. A. ( 1997;). Three new human herpesviruses (HHV6, 7, and 8). Lancet 349, 558–563.[CrossRef]
    [Google Scholar]
  100. Levy, J. A., Ferro, F., Greenspan, D. & Lennette, E. T. ( 1990;a). Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 335, 1047–1050.[CrossRef]
    [Google Scholar]
  101. Levy, J. A., Landay, A. & Lennette, E. T. ( 1990;b). Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol 28, 2362–2364.
    [Google Scholar]
  102. Lin, K. & Ricciardi, R. P. ( 1998;). The 41-kDa protein of human herpesvirus 6 specifically binds to viral DNA polymerase and greatly increases DNA synthesis. Virology 250, 210–219.[CrossRef]
    [Google Scholar]
  103. Lin, W. C., Moore, J. O., Mann, K. P., Traweek, S. T. & Smith, C. ( 1999;). Post transplant CD8+ γδ T-cell lymphoma associated with human herpes virus-6 infection. Leuk Lymphoma 33, 377–384.
    [Google Scholar]
  104. Liu, D. X., Gompels, U. A., Foa-Tomasi, L. & Campadelli-Fiume, G. ( 1993;). Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197, 12–22.[CrossRef]
    [Google Scholar]
  105. Ljungman, P., Wang, F.-Z., Clark, D. A., Emery, V. C., Remberger, M., Ringden, O. & Linde, A. ( 2000;). High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111, 774–781.
    [Google Scholar]
  106. Locatelli, G., Santoro, F., Veglia, F., Gobbi, A., Lusso, P. & Malnati, M. S. ( 2000;). Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol 38, 4042–4048.
    [Google Scholar]
  107. Luppi, M., Barozzi, P., Morris, C. & 7 other authors ( 1999;). Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 73, 754–759.
    [Google Scholar]
  108. Lusso, P. & Gallo, R. C. ( 1995;). Human herpesvirus 6 in AIDS. Immunol Today 16, 67–71.[CrossRef]
    [Google Scholar]
  109. Lusso, P., Markham, P. D., Tschachler, E., di Marzo Veronese, F., Salahuddin, S. Z., Ablashi, D. V., Pahwa, S., Krohn, K. & Gallo, R. C. ( 1988;). In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 167, 1659–1670.[CrossRef]
    [Google Scholar]
  110. Lusso, P., Ensoli, B., Markham, P. D., Ablashi, D. V., Salahuddin, S. Z., Tschachler, E., Wong-Staal, F. & Gallo, R. C. ( 1989;). Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 337, 370–373.[CrossRef]
    [Google Scholar]
  111. Lusso, P., Malnati, M., De Maria, A., Balotta, C., DeRocco, S. E., Markham, P. D. & Gallo, R. C. ( 1991;). Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 147, 685–691.
    [Google Scholar]
  112. Lusso, P., Malnati, M. S., Garzino-Demo, A., Crowley, R. W., Long, E. O. & Gallo, R. C. ( 1993;). Infection of natural killer cells by human herpesvirus 6. Nature 362, 458–462.[CrossRef]
    [Google Scholar]
  113. Lusso, P., Garzino-Demo, A., Crowley, R. W. & Malnati, M. S. ( 1995;). Infection of γ/δ T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 181, 1303–1310.[CrossRef]
    [Google Scholar]
  114. Manichanh, C., Olivier-Aubron, C., Lagarde, J.-P., Aubin, J.-T., Bossi, P., Gautheret-Dejean, A., Huraux, J.-M. & Agut, H. ( 2001;). Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol 82, 2767–2776.
    [Google Scholar]
  115. Martin, M. E., Nicholas, J., Thomson, B. J., Newman, C. & Honess, R. W. ( 1991;). Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6. J Virol 65, 5381–5390.
    [Google Scholar]
  116. Mattes, F. M., McLaughlin, J. E., Emery, V. C., Clark, D. A. & Griffiths, P. D. ( 2000;). Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. J Clin Pathol 53, 612–614.[CrossRef]
    [Google Scholar]
  117. Mayne, M., Cheadle, C., Soldan, S. S. & 7 other authors ( 2001;). Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 75, 11641–11650.[CrossRef]
    [Google Scholar]
  118. Mendez, J. C., Dockrell, D. H., Espy, M. J., Smith, T. F., Wilson, J. A., Harmsen, W. S., Ilstrup, D. & Paya, C. V. ( 2001;). Human β-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 183, 179–184.[CrossRef]
    [Google Scholar]
  119. Menotti, L., Mirandola, P., Locati, M. & Campadelli-Fiume, G. ( 1999;). Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes. J Virol 73, 325–333.
    [Google Scholar]
  120. Milne, R. S. B., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A. & Gompels, U. A. ( 2000;). RANTES binding and down-regulation by a novel human herpesvirus-6 β chemokine receptor. J Immunol 164, 2396–2404.[CrossRef]
    [Google Scholar]
  121. Mirandola, P., Menegazzi, P., Merighi, S., Ravaioli, T., Cassai, E. & Di Luca, D. ( 1998;). Temporal mapping of transcripts in herpesvirus 6 variants. J Virol 72, 3837–3844.
    [Google Scholar]
  122. Mori, Y., Yagi, H., Shimamoto, T., Isegawa, Y., Sunagawa, T., Inagi, R., Kondo, K., Tano, Y. & Yamanishi, K. ( 1998;). Analysis of human herpesvirus 6 U3 gene, which is a positional homolog of human cytomegalovirus UL 24 gene. Virology 249, 129–139.[CrossRef]
    [Google Scholar]
  123. Mori, Y., Dhepakson, P., Shimamoto, T., Ueda, K., Gomi, Y., Tani, H., Matsuura, Y. & Yamanishi, K. ( 2000;). Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J Virol 74, 6096–6104.[CrossRef]
    [Google Scholar]
  124. Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P. & Yamanishi, K. ( 2002;). Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol 76, 6750–6761.[CrossRef]
    [Google Scholar]
  125. Niederman, J. C., Lui, C.-R., Kaplan, M. H. & Brown, N. A. ( 1988;). Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet ii, 817–819.
    [Google Scholar]
  126. Nitsche, A., Muller, C. W., Radonic, A., Landt, O., Ellerbrok, H., Pauli, G. & Siegert, W. ( 2001;). Human herpesvirus 6A DNA is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183, 130–133.[CrossRef]
    [Google Scholar]
  127. Okuno, T., Takahashi, K., Balachandra, K., Shiraki, K., Yamanishi, K., Takahashi, M. & Baba, K. ( 1989;). Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27, 651–653.
    [Google Scholar]
  128. Osman, H. K., Peiris, J. S., Taylor, C. E., Warwicker, P., Jarrett, R. F. & Madeley, C. R. ( 1996;). ‘‘Cytomegalovirus disease’’ in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? J Med Virol 48, 295–301.[CrossRef]
    [Google Scholar]
  129. Pellett, P. E., Black, J. B. & Yamamoto, M. ( 1992;). Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv Virus Res 41, 1–52.
    [Google Scholar]
  130. Pfeiffer, B., Berneman, Z. N., Neipel, F., Chang, C. K., Tirwatnapong, S. & Chandran, B. ( 1993;). Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies. J Virol 67, 4611–4620.
    [Google Scholar]
  131. Pitkaranta, A., Piiparinen, H., Mannonen, L., Vesaluoma, M. & Vaheri, A. ( 2000;). Detection of human herpesvirus 6 and varicella-zoster virus in tear fluid of patients with Bell's palsy by PCR. J Clin Microbiol 38, 2753–2755.
    [Google Scholar]
  132. Pruksananonda, P., Hall, C. B., Insel, R. A. & 8 other authors ( 1992;). Primary human herpesvirus 6 infection in young children. N Engl J Med 326, 1445–1450.[CrossRef]
    [Google Scholar]
  133. Razonable, R. R., Fanning, C., Brown, R. A., Espy, M. J., Rivero, A., Wilson, J., Kremers, W., Smith, T. F. & Paya, C. V. ( 2002;). Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis 185, 110–113.[CrossRef]
    [Google Scholar]
  134. Reeves, W. C., Stamey, F. R., Black, J. B., Mawle, A. C., Stewart, J. A. & Pellett, P. E. ( 2000;). Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study. Clin Infect Dis 31, 48–52.[CrossRef]
    [Google Scholar]
  135. Robert, C., Aubin, J. T., Visse, B., Fillet, A. M., Huraux, J. M. & Agut, H. ( 1996;). Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6. Res Virol 147, 219–225.[CrossRef]
    [Google Scholar]
  136. Robinson, W. S. ( 1994;). Human herpesvirus 6. Curr Clin Top Infect Dis 14, 159–169.
    [Google Scholar]
  137. Rogers, J., Rohal, S., Carrigan, D. R., Kusne, S., Knox, K. K., Gayowski, T., Wagener, M. M., Fung, J. J. & Singh, N. ( 2000;). Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 69, 2566–2573.[CrossRef]
    [Google Scholar]
  138. Rosenfeld, C. S., Rybka, W. B., Weinbaum, D., Carrigan, D. R., Knox, K. K., Andrews, D. F. & Shadduck, R. K. ( 1995;). Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 23, 626–629.
    [Google Scholar]
  139. Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E. & Di Luca, D. ( 1998;). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A 95, 13911–13916.[CrossRef]
    [Google Scholar]
  140. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D. & 8 other authors ( 1986;). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234, 596–601.[CrossRef]
    [Google Scholar]
  141. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A. & Lusso, P. ( 1999;). CD46 is a cellular receptor for human herpesvirus 6. Cell 99, 817–827.[CrossRef]
    [Google Scholar]
  142. Saxinger, C., Polesky, H., Eby, N., Grufferman, S., Murphy, R., Tegtmeir, G., Parekh, V., Memon, S. & Hung, C. ( 1988;). Antibody reactivity with HBLV (HHV-6) in US populations. J Virol Methods 21, 199–208.[CrossRef]
    [Google Scholar]
  143. Schiewe, U., Neipel, F., Schreiner, D. & Fleckenstein, B. ( 1994;). Structure and transcription of an immediate-early region in the human herpesvirus 6 genome. J Virol 68, 2978–2985.
    [Google Scholar]
  144. Schirmer, E. C., Wyatt, L. S., Yamanashi, K., Rodriguez, W. J. & Frenkel, N. ( 1991;). Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A 88, 5922–5926.[CrossRef]
    [Google Scholar]
  145. Secchiero, P., Carrigan, D. R., Asano, Y., Benedetti, L., Crowley, R. W., Komaroff, A. L., Gallo, R. C. & Lusso, P. ( 1995;a). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171, 273–280.[CrossRef]
    [Google Scholar]
  146. Secchiero, P., Zella, D., Crowley, R. W., Gallo, R. C. & Lusso, P. ( 1995;b). Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 33, 2124–2130.
    [Google Scholar]
  147. Sieczkowski, L., Chandran, B. & Wood, C. ( 1995;). The human immunodeficiency virus tat gene enhances replication of human herpesvirus-6. Virology 211, 544–553.[CrossRef]
    [Google Scholar]
  148. Simmons, A., Demmrich, Y., La Vista, A. & Smith, K. ( 1992;). Replication of human herpesvirus 6 in epithelial cells in vitro. J Infect Dis 166, 202–205.[CrossRef]
    [Google Scholar]
  149. Singh, N. ( 2000;). Human herpesviruses-6, -7 and -8 in organ transplant recipients. Clin Microbiol Infect 6, 453–459.[CrossRef]
    [Google Scholar]
  150. Singh, N. & Carrigan D. R. ( 1996;). Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 124, 1065–1071.[CrossRef]
    [Google Scholar]
  151. Singh, N. & Paterson, D. L. ( 2000;). Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 69, 2474–2479.[CrossRef]
    [Google Scholar]
  152. Singh, N., Carrigan, D. R., Gayowski, T. & Marino, I. R. ( 1997;). Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 64, 674–678.[CrossRef]
    [Google Scholar]
  153. Singh, N., Husain, S., Carrigan, D. R., Knox, K. K., Weck, K. E., Wagener, M. M. & Gayowski, T. ( 2002;). Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 16, 92–96.[CrossRef]
    [Google Scholar]
  154. Soldan, S. S., Berti, R., Salem, N. & 9 other authors ( 1997;). Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3, 1394–1397.[CrossRef]
    [Google Scholar]
  155. Soldan, S. S., Fogdell-Hahn, A., Brennan, M. B., Mittleman, B. B., Ballerini, C., Massacesi, L., Seya, T., McFarland, H. F. & Jacobson, S. ( 2001;). Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 50, 486–493.[CrossRef]
    [Google Scholar]
  156. Sugaya, N., Yoshikawa, T., Miura, M., Ishizuka, T., Kawakami, C. & Asano, Y. ( 2002;). Influenza encephalopathy associated with infection with human herpesvirus 6 and/or human herpesvirus 7. Clin Infect Dis 34, 461–466.[CrossRef]
    [Google Scholar]
  157. Suzuki, Y., Inagi, R., Aono, T., Yamanishi, K. & Shiohara, T. ( 1998;). Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134, 1108–1112.
    [Google Scholar]
  158. Takagi, M., Unno, A., Maruyama, T., Kaneko, K. & Obinata, K. ( 1996;). Human herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome. Pediatr Hematol Oncol 13, 451–456.[CrossRef]
    [Google Scholar]
  159. Takahashi, K., Sonoda, S., Higashi, K., Kondo, T., Takahashi, H., Takahashi, M. & Yamanishi, K. ( 1989;). Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 63, 3161–3163.
    [Google Scholar]
  160. Takemoto, M., Shimamoto, T., Isegawa, Y. & Yamanashi, K. ( 2001;). The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J Virol 75, 10149–10160.[CrossRef]
    [Google Scholar]
  161. Thomson, B. J., Efstathiou, S. & Honess, R. W. ( 1991;). Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 351, 78–80.[CrossRef]
    [Google Scholar]
  162. Tigue, N. J. & Kay, J. ( 1998;). Autoprocessing and peptide substrates for human herpesvirus 6 proteinase. J Biol Chem 273, 26441–26446.[CrossRef]
    [Google Scholar]
  163. Tong, C. Y., Bakran, A., Williams, H., Cheung, C. Y. & Peiris, J. S. ( 2000;). Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 70, 213–216.
    [Google Scholar]
  164. Torrisi, M. R., Gentile, M., Cardinali, G., Cirone, M., Zompetta, C., Lotti, L. V., Frati, L. & Faggioni, A. ( 1999;). Intracellular transport and maturation pathway of human herpesvirus 6. Virology 257, 460–471.[CrossRef]
    [Google Scholar]
  165. van den Bosch, G., Locatelli, G., Geerts, L. & 7 other authors ( 2001;). Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol 39, 2308–2310.[CrossRef]
    [Google Scholar]
  166. van Loon, N. M., Gummuluru, S., Sherwood, D. J., Marentes, R., Hall, C. B. & Dewhurst, S. ( 1995;). Direct sequence analysis of human herpesvirus 6 (HHV-6) sequences from infants and comparison of HHV-6 sequences from mother/infant pairs. Clin Infect Dis 21, 1017–1019.[CrossRef]
    [Google Scholar]
  167. Wang, F. Z., Dahl, H., Linde, A., Brytting, M., Ehrnst, A. & Ljungman, P. ( 1996;). Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 88, 3615–3620.
    [Google Scholar]
  168. Wang, F. Z., Linde, A., Hagglund, H., Testa, M., Locasciulli, A. & Ljungman, P. ( 1999;). Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 28, 562–568.[CrossRef]
    [Google Scholar]
  169. Ward, K. N., Gray, J. J. & Efstathiou, S. ( 1989;). Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 28, 69–72.[CrossRef]
    [Google Scholar]
  170. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. & Kurata, T. ( 1988;). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i, 1065–1067.
    [Google Scholar]
  171. Yasukawa, M., Yakushijin, Y., Furukawa, M. & Fujita, S. ( 1993;). Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 67, 6259–6264.
    [Google Scholar]
  172. Yasukawa, M., Inoue, Y., Ohminami, H., Terada, K. & Fujita, S. ( 1998;). Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J Gen Virol 79, 143–147.
    [Google Scholar]
  173. Yasukawa, M., Hasegawa, A., Sakai, I. & 8 other authors ( 1999;). Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J Immunol 162, 5417–5422.
    [Google Scholar]
  174. Yoshida, M., Yamada, M., Tsukazaki, T., Chatterjee, S., Lakeman, F. D., Nii, S. & Whitley, R. J. ( 1998;). Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res 40, 73–84.[CrossRef]
    [Google Scholar]
  175. Yoshikawa, T., Asano, Y., Ihira, M. & 9 other authors ( 2002;). Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 185, 847–853.[CrossRef]
    [Google Scholar]
  176. Zerr, D. M., Gooley, T. A., Yeung, L., Huang, M. L., Carpenter, P., Wade, J. C., Corey, L. & Anasetti, C. ( 2001;). Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33, 763–771.[CrossRef]
    [Google Scholar]
  177. Zerr, D. M., Gupta, D., Huang, M.-L., Carter, R. & Corey, L. ( 2002;). Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 34, 309–317.[CrossRef]
    [Google Scholar]
  178. Zhou, Y., Chandran, B. & Wood, C. ( 1997;). Transcriptional patterns of the pCD41 (U27) locus of human herpesvirus 6. J Virol 71, 3420–3430.
    [Google Scholar]
  179. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y. & Yamanishi, K. ( 1999;). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 73, 5926–5933.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05074-0
Loading
/content/journal/jmm/10.1099/jmm.0.05074-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error